2MA8

Solution NMR Structure of Salmonella typhimurium LT2 Secreted Protein SrfN: Northeast Structural Genomics Consortium Target StR109

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
2	2D 1H-13C HSQC ali	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
3	2D 1H-13C ct-HSQC ali	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
4	2D 1H-13C HSQC aro	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
5	2D 1H-13C ct-HSQC aro	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
6	3D HNCO	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
7	GFT (4,3)D CABCA(CO)NHN	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
8	GFT (4,3)D HNNCABCA	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
9	GFT (4,3)D HABCAB(CO)NHN	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
10	GFT (4,3)D HCCH-COSY ali	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
11	GFT (4,3)D HCCH-COSY aro	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
12	3D 1H-13C/15N simNOESY	1.38 mM [U-100% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
13	3D 1H-13C X-filtered NOESY	1.2 mM [U-100% 13C; U-100% 15N] StR109 subunit, 1.2 mM StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
14	2D 1H-13C 28ms ct-HSQC	1.8 mM [U-5% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298
15	2D 1H-13C 56ms ct-HSQC	1.8 mM [U-5% 13C; U-100% 15N] StR109 subunit, 100 mM sodium chloride, 100 mM DTT, 5 mM CaCl2, 20 mM MES, 0.02 % sodium azide	95% H2O/5% D2O	115	6.5	1 atm	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	600
2	Varian	INOVA	750

NMR Refinement
Method	Details	Software
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	low energy structures with few restraint violations and reasonable geometry
Conformers Calculated Total Number	40
Conformers Submitted Total Number	20
Representative Model	1 (first structure that meets the conformer selection criteria)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	CYANA	2.1	P.GUNTERT ET AL.
2	refinement	CYANA	2.1	P.GUNTERT ET AL.
3	collection	VNMR	6.1C	Varian
4	data analysis	XEASY	1.3.13	Bartels et al.
5	chemical shift assignment	AutoAssign	1.15.1	Zimmerman, Moseley, Kulikowski, Montelione
6	data analysis	CARA	1.5.5	Keller et al.
7	processing	PROSA	6.0.2	Guntert
8	refinement	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read
9	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
10	data analysis	Sparky		Goddard

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.